Abstract
Pain is a frequent yet underrecognized symptom of Parkinson’s disease (PD). Although routine clinical neurological examination generally does not reveal any abnormality of sensation in persons with PD, objective abnormalities of proprioceptive function and sensorimotor integration have been demonstrated with sophisticated testing. Painful symptoms pose a considerable diagnostic and therapeutic challenge to the clinician. For diagnostic purposes, it is helpful to classify painful or unpleasant sensory symptoms into one or more of the following five categories: musculoskeletal pain, radicular or neuropathic pain, dystonia-related pain, akathitic discomfort, or primary, central parkinsonian pain. The identification of parkinsonian pain is vitally important for the effective diagnosis and treatment of pain in PD.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lewy F. Die Lehre vom Tonus und der Bewegung Zugleich Systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der Paralysis Agitans. Berlin: Springer; 1923.
Souques M. Des douleurs dans la paralysie agitante. Rev Neurol (Paris). 1921;37:629–33.
Wilson S. Neurology. New York: Hafner; 1940.
Charcot JM. Lectures on the diseases of the nervous system, delivered at La Salpetrie\0300re. London: The New Sydenham Society; 1877.
Beiske AG, et al. Pain in Parkinson’s disease: prevalence and characteristics. Pain. 2009;141(1–2):173–7.
Defazio G, et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol. 2008;65(9):1191–4.
Lee MA, et al. A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage. 2006;32(5):462–9.
Negre-Pages L, et al. Chronic pain in Parkinson’s disease: the cross-sectional French DoPaMiP survey. Mov Disord. 2008;23(10):1361–9.
Quittenbaum BH, Grahn B. Quality of life and pain in Parkinson’s disease: a controlled cross-sectional study. Parkinsonism Relat Disord. 2004;10(3):129–36.
Roh JH, et al. The relationship of pain and health-related quality of life in Korean patients with Parkinson’s disease. Acta Neurol Scand. 2009;119(6):397–403.
Silva EG, Viana MA, Quagliato EM. Pain in Parkinson’s disease: analysis of 50 cases in a clinic of movement disorders. Arq Neuropsiquiatr. 2008;66(1):26–9.
Tinazzi M, et al. Pain and motor complications in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2006;77(7):822–5.
Vela L, et al. Pain-pressure threshold in patients with Parkinson’s disease with and without dyskinesia. Parkinsonism Relat Disord. 2007;13(3):189–92.
Sigwald J, Solignac J. Manifestations douloureuses de la maldie de Parkinson et parasthesies provoquees par les neuroleptiques. Sem Hop Paris. 1960;41:2222–5.
Snider SR, et al. Primary sensory symptoms in parkinsonism. Neurology. 1976;26(5):423–9.
Koller WC. Sensory symptoms in Parkinson’s disease. Neurology. 1984;34(7):957–9.
Goetz CG, et al. Pain in Parkinson’s disease. Mov Disord. 1986;1(1):45–9.
Witjas T, et al. Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology. 2002;59(3):408–13.
Almeida TF, Roizenblatt S, Tufik S. Afferent pain pathways: a neuroanatomical review. Brain Res. 2004;1000(1–2):40–56.
Pratorius B, Kimmeskamp S, Milani TL. The sensitivity of the sole of the foot in patients with Morbus Parkinson. Neurosci Lett. 2003;346(3):173–6.
Zia S, Cody F, O’Boyle D. Joint position sense is impaired by Parkinson’s disease. Ann Neurol. 2000;47(2):218–28.
Weder BJ, et al. Impaired somatosensory discrimination of shape in Parkinson’s disease: association with caudate nucleus dopaminergic function. Hum Brain Mapp. 1999;8(1):1–12.
Zia S, Cody FW, O’Boyle DJ. Discrimination of bilateral differences in the loci of tactile stimulation is impaired in subjects with Parkinson’s disease. Clin Anat. 2003;16(3):241–7.
Diamond SG, Schneider JS, Markham CH. Oral sensorimotor defects in patients with Parkinson’s disease. Adv Neurol. 1987;45:335–8.
Schneider JS, Diamond SG, Markham CH. Deficits in orofacial sensorimotor function in Parkinson’s disease. Ann Neurol. 1986;19(3):275–82.
Schneider JS, Diamond SG, Markham CH. Parkinson’s disease: sensory and motor problems in arms and hands. Neurology. 1987;37(6):951–6.
Nolano M, et al. Sensory deficit in Parkinson’s disease: evidence of a cutaneous denervation. Brain. 2008;131(Pt 7):1903–11.
Ohsawa Y, et al. Reduced amplitude of the sural nerve sensory action potential in PARK2 patients. Neurology. 2005;65(3):459–62.
Klockgether T, et al. A defect of kinesthesia in Parkinson’s disease. Mov Disord. 1995;10(4):460–5.
Jobst EE, et al. Sensory perception in Parkinson disease. Arch Neurol. 1997;54(4):450–4.
Khudados E, Cody FW, O’Boyle DJ. Proprioceptive regulation of voluntary ankle movements, demonstrated using muscle vibration, is impaired by Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1999;67(4):504–10.
Rickards C, Cody FW. Proprioceptive control of wrist movements in Parkinson’s disease. Reduced muscle vibration-induced errors. Brain. 1997;120(Pt 6):977–90.
Rossini PM, Filippi MM, Vernieri F. Neurophysiology of sensorimotor integration in Parkinson’s disease. Clin Neurosci. 1998;5(2):121–30.
Djaldetti R, et al. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology. 2004;62(12):2171–5.
Lim SY, et al. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson’s disease? Mov Disord. 2008;23(12):1689–95.
Gerdelat-Mas A, et al. Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study. J Neurol Neurosurg Psychiatry. 2007;78(10):1140–2.
Mylius V, et al. Pain sensitivity and descending inhibition of pain in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2009;80(1):24–8.
Schestatsky P, et al. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology. 2007;69(23):2162–9.
Tinazzi M, et al. Muscular pain in Parkinson’s disease and nociceptive processing assessed with CO2 laser-evoked potentials. Mov Disord. 2010;25(2):213–20.
Brefel-Courbon C, et al. Effect of levodopa on pain threshold in Parkinson’s disease: a clinical and positron emission tomography study. Mov Disord. 2005;20(12):1557–63.
Skljarevski V, Ramadan NM. The nociceptive flexion reflex in humans – review article. Pain. 2002;96(1–2):3–8.
Garcia-Larrea L, Frot M, Valeriani M. Brain generators of laser-evoked potentials: from dipoles to functional significance. Neurophysiol Clin. 2003;33(6):279–92.
Tinazzi M, et al. Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing. J Neurol Sci. 2009;276(1–2):153–8.
Treede RD, Lorenz J, Baumgartner U. Clinical usefulness of laser-evoked potentials. Neurophysiol Clin. 2003;33(6):303–14.
Tinazzi M, et al. Abnormal processing of the nociceptive input in Parkinson’s disease: a study with CO2 laser evoked potentials. Pain. 2008;136(1–2):117–24.
Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain. 1995;60(1):3–38.
Juri C, Rodriguez-Oroz M, Obeso JA. The pathophysiological basis of sensory disturbances in Parkinson’s disease. J Neurol Sci. 2010;289(1–2):60–5.
Lidsky TI, Manetto C, Schneider JS. A consideration of sensory factors involved in motor functions of the basal ganglia. Brain Res. 1985;356(2):133–46.
Saade NE, et al. Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Res. 1997;751(1):1–12.
Braak H, et al. Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol. 2007;113(4):421–9.
Scherder E, et al. Pain in Parkinson’s disease and multiple sclerosis: its relation to the medial and lateral pain systems. Neurosci Biobehav Rev. 2005;29(7):1047–56.
Gowers WRS. A manual of diseases of the nervous system, vol. 8. London: J. & A. Churchill; 1886.
Gilbert GJ. Biceps pain as the presenting symptom of Parkinson disease: effective treatment with L-dopa. South Med J. 2004;97(8):776–7.
Riley D, et al. Frozen shoulder and other shoulder disturbances in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1989;52(1):63–6.
Duvoisin RC, Marsden CD. Note on the scoliosis of Parkinsonism. J Neurol Neurosurg Psychiatry. 1975;38(8):787–93.
Indo T, Ando K. Studies on the scoliosis of Parkinsonism (author’s transl). Rinsho Shinkeigaku. 1980;20(1):40–6.
Grimes JD, et al. Clinical and radiographic features of scoliosis in Parkinson’s disease. Adv Neurol. 1987;45:353–5.
Djaldetti R, et al. Camptocormia (bent spine) in patients with Parkinson’s disease – characterization and possible pathogenesis of an unusual phenomenon. Mov Disord. 1999;14(3):443–7.
Wunderlich S, et al. Camptocormia in Parkinson’s disease mimicked by focal myositis of the paraspinal muscles. Mov Disord. 2002;17(3):598–600.
Charcot JM. Lectures on the diseases of the nervous system. London: The New Sydenham Society; 1877.
Bissonnette B. Pseudorheumatoid deformity of the feet associated with parkinsonism. J Rheumatol. 1986;13(4):825–6.
Cordivari C, et al. Treatment of dystonic clenched fist with botulinum toxin. Mov Disord. 2001;16(5):907–13.
Gortvai P. Deformities of the hands and feet in Parkinsonism and their reversibility by operation. J Neurol Neurosurg Psychiatry. 1963;26:33–6.
Reynolds FW, Petropoulous GC. Hand deformities in Parkinsonism. J Chronic Dis. 1965;18:593–5.
Broetz D, et al. Radicular and nonradicular back pain in Parkinson’s disease: a controlled study. Mov Disord. 2007;22(6):853–6.
Pullman SL, Elibol B, Fahn S. Modulation of parkinsonian tremor by radial nerve palsy. Neurology. 1994;44(10):1861–4.
Berg D, Becker G, Reiners K. Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica. J Neural Transm. 1999;106(7–8):725–8.
Hillen ME, Sage JI. Nonmotor fluctuations in patients with Parkinson’s disease. Neurology. 1996;47(5):1180–3.
Poewe WH, Lees AJ, Stern GM. Dystonia in Parkinson’s disease: clinical and pharmacological features. Ann Neurol. 1988;23(1):73–8.
Quinn NP. Classification of fluctuations in patients with Parkinson’s disease. Neurology. 1998;51(2 Suppl 2):S25–9.
Quinn NP, et al. Painful Parkinson’s disease. Lancet. 1986;1(8494):1366–9.
Currie LJ, et al. Early morning dystonia in Parkinson’s disease. Neurology. 1998;51(1):283–5.
Duvoisin RC, Yahr MD, Lieberman J. The striatal foot. Trans Am Neurol Assoc. 1972;97:267.
Ilson J, Fahn S, Cote L. Painful dystonic spasms in Parkinson’s disease. Adv Neurol. 1984;40:395–8.
Melamed E. Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson’s disease. Arch Neurol. 1979;36(5):308–10.
Nausieda PA, Weiner WJ, Klawans HL. Dystonic foot response of Parkinsonism. Arch Neurol. 1980;37(3):132–6.
Poewe W, et al. Foot dystonia in Parkinson’s disease: clinical phenomenology and neuropharmacology. Adv Neurol. 1987;45:357–60.
Stewart P. Paralysis agitans: with an account of a new symptom. Lancet. 1898;2:1258–60.
Lees AJ, Hardie RJ, Stern GM. Kinesigenic foot dystonia as a presenting feature of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1984;47(8):885.
Pollak P, Tranchant C. Les autres symptomes de la phase evoluee de la maladie de Parkinson. Rev Neurol (Paris). 2000;156(Suppl):165–73.
Lees AJ, Shaw KM, Stern GM. Baclofen in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1978;41(8):707–8.
Quinn N, Marsden CD. Lithium for painful dystonia in Parkinson’s disease. Lancet. 1986;1(8494):1377.
Pacchetti C, et al. “Off” painful dystonia in Parkinson’s disease treated with botulinum toxin. Mov Disord. 1995;10(3):333–6.
Limousin P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 1998;339(16):1105–11.
Loher TJ, et al. Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2002;73(4):395–9.
Ford B, et al. Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol. 1996;53(12):1241–6.
Dejerine J, Roussy G. Le syndrome thalamique. Rev Neurol. 1906;14:521–8.
Ford B, et al. Oral and genital pain syndromes in Parkinson’s disease. Mov Disord. 1996;11(4):421–6.
Grushka M, Sessle BJ. Burning mouth syndrome. Dent Clin North Am. 1991;35(1):171–84.
Sage JI, Kortis HI, Sommer W. Evidence for the role of spinal cord systems in Parkinson’s disease-associated pain. Clin Neuropharmacol. 1990;13(2):171–4.
Factor SA, Brown DL, Molho ES. Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson’s disease. Mov Disord. 2000;15(1):167–9.
Juri C, et al. Pain and dyskinesia in Parkinson’s disease. Mov Disord. 2010;25(1):130–2.
Samura K, et al. Intractable facial pain in advanced Parkinson’s disease alleviated by subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry. 2008;79(12):1410–1.
Kim HJ, et al. Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol. 2008;255(12):1889–94.
Comella CL, Goetz CG. Akathisia in Parkinson’s disease. Mov Disord. 1994;9(5):545–9.
Lang AE, Johnson K. Akathisia in idiopathic Parkinson’s disease. Neurology. 1987;37(3):477–81.
Javoy-Agid F, Agid Y. Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology. 1980;30(12):1326–30.
Linazasoro G, Marti Masso JF, Suarez JA. Nocturnal akathisia in Parkinson’s disease: treatment with clozapine. Mov Disord. 1993;8(2):171–4.
Trosch RM, et al. Clozapine use in Parkinson’s disease: a retrospective analysis of a large multicentered clinical experience. Mov Disord. 1998;13(3):377–82.
Van Tol HH, et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1991;350(6319):610–4.
Chokroverty S, Jankovic J. Restless legs syndrome: a disease in search of identity. Neurology. 1999;52(5):907–10.
Indo T, Naito A, Sobue I. Clinical characteristics of headache in Parkinson’s disease. Headache. 1983;23(5):211–2.
Indo T, Takahashi A. Early morning headache of Parkinson’s disease: a hitherto unrecognized symptom? Headache. 1987;27(3):151–4.
Meco G, et al. Headache in Parkinson’s disease. Headache. 1988;28(1):26–9.
Goetz CG, et al. Relationships among pain, depression, and sleep alterations in Parkinson’s disease. Adv Neurol. 1987;45:345–7.
Starkstein SE, Preziosi TJ, Robinson RG. Sleep disorders, pain, and depression in Parkinson’s disease. Eur Neurol. 1991;31(6):352–5.
Ehrt U, Larsen JP, Aarsland D. Pain and its relationship to depression in Parkinson disease. Am J Geriatr Psychiatry. 2009;17(4):269–75.
Djaldetti R, et al. The effect of duloxetine on primary pain symptoms in Parkinson disease. Clin Neuropharmacol. 2007;30(4):201–5.
Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14(2):223–36. Discussion 222.
Hammond WA. A treatise on diseases of the nervous system. New York: D. Appleton; 1871. p. iv, 5–7, ix–xxv, 33–754.
Artieda J, et al. Temporal discrimination is abnormal in Parkinson’s disease. Brain. 1992;115(Pt 1):199–210.
Nebe A, Ebersbach G. Pain intensity on and off levodopa in patients with Parkinson’s disease. Mov Disord. 2009;24(8):1233–7.
Quinn NP, et al. Contractures of the extremities in parkinsonian subjects: a report of three cases with a possible association with bromocriptine treatment. Clin Neuropharmacol. 1988;11(3):268–77.
Laitinen LV, Bergenheim AT, Hariz MI. Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s disease. J Neurosurg. 1992;76(1):53–61.
Canavero S. Central pain and Parkinson disease. Arch Neurol. 2009;66(2):282–3. Author reply 283.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hess, C., Ford, B. (2013). Pain in Parkinson’s Disease: Pathophysiology, Classification, and Clinical Approach. In: Pfeiffer, R.F., Bodis-Wollner, I. (eds) Parkinson’s Disease and Nonmotor Dysfunction. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-429-6_24
Download citation
DOI: https://doi.org/10.1007/978-1-60761-429-6_24
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-428-9
Online ISBN: 978-1-60761-429-6
eBook Packages: MedicineMedicine (R0)